MCAC Likely Will Assess Potential Postmarket Surveillance Of LVADs
This article was originally published in The Gray Sheet
Executive Summary
CMS expects the Medicare Coverage Advisory Committee to consider recommending postmarket registries of left-ventricular assist devices as a condition of national coverage